The global race to understand COVID-19 variants
A new trial including the University of Melbourne is investigating who could remain susceptible to SARS-CoV-2 variants after COVID-19 infection or vaccination
How your blood can help understand COVID-19 vaccine responses
A biobank will collect samples from those having their COVID-19 vaccine to help researchers understand coronavirus immunity, say University of Melbourne experts
Reinfection in COVID-19 – Part three
What are the implications of reinfection for vaccines, antibody passports and herd immunity asks University of Melbourne's Prof Peter Doherty?
Reinfection in COVID-19- Part two
What do cases of reinfection tell us about protective immunity against SARS-CoV-2 asks the University of Melbourne’s Prof Peter Doherty?
Affinity, avidity, IgM, IgG, serological surveys and ‘antibody passports’
The University of Melbourne's Peter Doherty explains our immune response to COVID-19 and what 'antibody passports' look for after vaccination or infection.
How severe viral infections overwhelm immune cells
University of Melbourne researchers uncover new mechanisms behind how cancer and severe viral infections like HIV and COVID-19 can exhaust our immune systems
What malaria can tell us about ‘switching off’ diseases like HIV
New University of Melbourne research on our body’s inflammation response to malaria could open up new treatments for viral and autoimmune diseases like HIV.
What we do (and don't) know about lupus
Lupus affects millions worldwide; researchers from the University of Melbourne are working to treat the disease without ‘turning off’ the immune system.
Lifting the lid on HIV
Researchers at the University of Melbourne are helping to open up the HIV virus, exposing new treatment targets that could help eradicate the deadly disease.
Our ‘killer’ cells’ role in life-long flu vaccine
Killer immune cells that can fight all strains of flu virus provide the potential for a universal, one-shot flu vaccine, University of Melbourne research shows